Table I.
Demographic information of the patients in each group.
| Demographics | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | Control |
|---|---|---|---|---|---|---|
| Gender | ||||||
| Male | 14 | 13 | 10 | 9 | 15 | 10 |
| Female | 0 | 1 | 0 | 1 | 5 | 5 |
| Age, years (range) | 15.4 (4–29) | 19 (12–34) | 21.5 (7–45) | 17.7 (7–28) | 28.9 (15–45) | 24.9 (7–43) |
| Onset age, years (range) | 15.1 (4–29) | 18.8 (12–33) | 20.7 (6–44) | 17.1 (6–28) | 17.6 (12–36) | - |
| ADV, months (range) | 1.3 (0.3–3) | 4.3 (3.3–5) | 7.2 (6–9) | 10.5 (9–12) | 137.5 (14–360) | - |
| LogMAR BCVA score | 1.5 (0.4–2.9) | 1.6 (1.0–2.9) | 1.6 (0.3–2.4) | 1.6 (0.1–2.5) | 1.8 (0.1–4.1) | - |
ADV, average duration of disease; Logmar, logarithm of the minimal angle of resolution; BCVA, best corrected visual acuity; group 1, disease duration ≤3 months; group 2, disease duration 4–6 months; group 3, disease duration 7–9 months; group 4, disease duration 10–12 months; group 5, disease duration >12 months.